Loading...
Unpredicted Severe Toxicity after 5-Fluorouracil Treatment due to Dihydropyrimidine Dehydrogenase Deficiency
Dihydropyrimidine dehydrogenase (DPD) is the initial and rate-limiting enzyme in the catabolism of 5-fluorouracil (5-FU). Thus, patients with a DPD deficiency are at risk of developing severe 5-FU-associated toxicity. A 37-year-old female with gastric cancer underwent a curative operation, followed...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Korean Association of Internal Medicine
2006
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3891063/ https://ncbi.nlm.nih.gov/pubmed/16646564 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2006.21.1.43 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|